Clinical trial
Venlafaxine for Hot Flashes After Breast Cancer
NCT00198250 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00198250 |
|---|---|
| Title | Venlafaxine for Hot Flashes After Breast Cancer |
| Official title | Venlafaxine for Hot Flashes After Breast Cancer |
| Lead sponsor | Indiana University School of Medicine, Other |
| Collaborators | Vanderbilt University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | venlafaxine |
| Enrollment | 75 |
| Start date | May 1, 2000 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 14, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: